{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:36:13Z","timestamp":1772127373873,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejca.2021.10.017","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T17:10:57Z","timestamp":1637169057000},"page":"275-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Significant decrease of the pathological stage I rectal carcinoma in the era of neoadjuvant therapy\u2014A matter of concern"],"prefix":"10.1016","volume":"159","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-196X","authenticated-orcid":false,"given":"Sigmar","family":"Stelzner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Puffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea","family":"Bleyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2868-5155","authenticated-orcid":false,"given":"Matthias","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Witzigmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soeren T.","family":"Mees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.10.017_bib1","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/archsurg.133.8.894","article-title":"The Basingstoke Experience of total mesorectal excision, 1978 \u2013 1997","volume":"133","author":"Heald","year":"1998","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/DCR.0b013e31820eeb37","article-title":"Neoadjuvant therapy in rectal cancer","volume":"54","author":"Fleming","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejca.2021.10.017_bib3","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.10.017_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.10.017_bib5","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bjs.9811","article-title":"Tumour regression in the randomized Stockholm III trial of radiotherapy regimens for rectal cancer","volume":"102","author":"Pettersson","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib6","series-title":"S3-Guideline colorectal cancer","year":"2019"},{"key":"10.1016\/j.ejca.2021.10.017_bib7","doi-asserted-by":"crossref","first-page":"806","DOI":"10.6004\/jnccn.2020.0032","article-title":"NCCN guidelines insights: rectal cancer. Version 6.2020","volume":"18","author":"Benson","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejca.2021.10.017_bib8","first-page":"140","article-title":"Current and future cancer staging after neoadjuvant treatment for solid tumours","volume":"71","author":"Byrd","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2021.10.017_bib9","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/bjs.10879","article-title":"Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial","volume":"105","author":"Ruppert","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00384-020-03792-8","article-title":"Association of certification, improved quality and better oncological outcomes for rectal cancer in a specialized colorectal unit","volume":"36","author":"Jacob","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejca.2021.10.017_bib11","series-title":"TNM classification of malignant tumours","year":"1997"},{"key":"10.1016\/j.ejca.2021.10.017_bib12","series-title":"TNM classification of malignant tumours","year":"2002"},{"key":"10.1016\/j.ejca.2021.10.017_bib13","series-title":"TNM classification of malignant tumours","year":"2010"},{"key":"10.1016\/j.ejca.2021.10.017_bib14","series-title":"TNM classification of malignant tumours","year":"2017"},{"key":"10.1016\/j.ejca.2021.10.017_bib15","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1055\/s-2004-813699","article-title":"S3-guideline conference \u201ccolorectal cancer 2004\u201d","volume":"42","author":"Schmiegel","year":"2004","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.ejca.2021.10.017_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.2006.08.3675","article-title":"Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer","volume":"25","author":"R\u00f6del","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/bjs.11590","article-title":"Dutch ColoRectal Audit Group. MRI cT1-2 rectal cancer staging accuracy: a population based study","volume":"107","author":"Detering","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cgh.2014.08.036","article-title":"Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany","volume":"13","author":"Brenner","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2021.10.017_bib19","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1053\/j.gastro.2012.03.022","article-title":"Efficacy of a nationwide screening colonoscopy program for colorectal cancer","volume":"142","author":"Pox","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2021.10.017_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1463-1318.2009.02069.x","article-title":"Downstaging of colorectal cancer by the National Bowel Cancer Screening programme in England: first round data from the first centre","volume":"12","author":"Ellul","year":"2010","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejca.2021.10.017_bib21","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2011-300843","article-title":"English bowel cancer screening evaluation committee. Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests","volume":"61","author":"Logan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejca.2021.10.017_bib22","first-page":"1772","article-title":"Stage migration in curative colorectal cancer resections","author":"Quinn","year":"2013","journal-title":"JGHR"},{"issue":"Suppl","key":"10.1016\/j.ejca.2021.10.017_bib23","first-page":"60","article-title":"Prognostic factors of rectum carcinoma \u2013 experience of the German multicentre study SGCRC","volume":"81","author":"Hermanek","year":"1995","journal-title":"Tumouri"},{"key":"10.1016\/j.ejca.2021.10.017_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1463-1318.2003.00506.x","article-title":"Total mesorectal excision for rectal cancer \u2013 what can be achieved by a national audit?","volume":"5","author":"Wibe","year":"2003","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejca.2021.10.017_bib25","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/bjs.5679","article-title":"The Swedish rectal cancer registry","volume":"94","author":"P\u00e5hlman","year":"2007","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00268-001-0182-5","article-title":"Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2400 patients \u2013 monoinstitutional experience","volume":"26","author":"Staib","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.radonc.2017.04.012","article-title":"Preoperative chemoradiotherapy for rectal cancer and impact on outcomes - a population-based study","volume":"123","author":"\u00c5sli","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib28","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/ijc.31785","article-title":"An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients","volume":"143","author":"Brouwer","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2021.10.017_bib29","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1200\/JCO.2013.49.1860","article-title":"Practice patterns and long-term survival for early-stage rectal cancer","volume":"31","author":"Stitzenberg","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib30","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ejso.2016.12.019","article-title":"Dutch Surgical Colorectal Cancer Audit Group. Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline","volume":"43","author":"Gietelink","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ejso.2018.12.006","article-title":"Early local recurrence and one-year mortality of rectal cancer after restricting the neoadjuvant therapy regime","volume":"45","author":"Tersteeg","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2019.03.036","article-title":"Determinimg the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines","volume":"136","author":"Hammarstr\u00f6m","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib33","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ejca.2015.03.020","article-title":"Expected long-term impact of the German screening colonoscopy programme on colorectal cancer prevention: analyses based on 4,407,971 screening colonoscopies","volume":"51","author":"Brenner","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2021.10.017_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1200\/JCO.2007.13.5434","article-title":"cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted","volume":"20","author":"Guillem","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib35","first-page":"749","article-title":"Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal adenocarcinoma: prospective observational study","volume":"333","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2021.10.017_bib36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1470-2045(12)70187-0","volume":"13","author":"R\u00f6del","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1463-1318.2009.02076.x","article-title":"Individualized MRI-based neoadjuvant chemoradiation for middle and lower rectal cancer","volume":"13","author":"Hermanek","year":"2010","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejca.2021.10.017_bib38","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1245\/s10434-018-07096-8","article-title":"Impact of long-course neoadjuvant radiation on postoperative low anterior resection syndrome and quality of life in rectal cancer; post hoc analysis of a randomized controlled trial","volume":"26","author":"Sun","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib39","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1245\/s10434-009-0613-3","article-title":"Accuracy of high-resolution magnetic resonance imaging in preoperative staging of rectal cancer","volume":"16","author":"Akasu","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2021.10.017_bib40","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00330-005-0084-2","article-title":"Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging","volume":"16","author":"Kim","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejca.2021.10.017_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijsu.2016.01.098","article-title":"Predictors of circumferential resection margin involvement in surgically resected rectal cancer: a retrospective review of 23,464 patients in the US National Cancer Database","volume":"28","author":"Al-Sukhni","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib42","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/DCR.0000000000001229","article-title":"Selection of patients with rectal cancer for preoperative chemoradiotherapy: are T category and nodal status all that matters?","volume":"62","author":"Pooni","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejca.2021.10.017_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jamcollsurg.2020.06.023","article-title":"Merkel S, and the other members of the OCUM Group. Avoidance of overtreatment of rectal cancer by selective chemoradiotherapy:results of the optimized surgery and MRI based multimodal therapy trial","volume":"231","author":"Ruppert","year":"2020","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/00015458.2016.1259883","article-title":"Accuracy of pre-treatment locoregional rectal cancer staging in a national improvement project","volume":"117","author":"Op de Beeck","year":"2017","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.ejca.2021.10.017_bib45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s003840100309","article-title":"The prognostic inhomogeneity in pT3 rectal carcinomas","volume":"16","author":"Merkel","year":"2001","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejca.2021.10.017_bib46","article-title":"MRI-diagnosed tumour deposits and EMVI status have\u00a0superior prognostic accuracy to current clinical TNM staging in rectal cancer","author":"Lord","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy. Long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2021.10.017_bib48","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/DCR.0b013e3181ba14ed","article-title":"Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period","volume":"52","author":"Habr-Gama","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejca.2021.10.017_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10350-007-9080-8","article-title":"Complete clinical response after preoperative chemoradiation in rectal cancer: is a \u201cwait and see\u201d policy justified?","volume":"51","author":"Glynne-Jones","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejca.2021.10.017_bib50","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.4008","article-title":"Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial","author":"Garcia-Aguilar","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2021.10.017_bib51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.dld.2020.04.022","article-title":"Management of T1 colorectal cancers detected at screening colonoscopy: a study from the French national screening programme","volume":"52","author":"Grainville","year":"2020","journal-title":"Dig Liver Dis"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921011710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921011710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:34:59Z","timestamp":1760733299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921011710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":51,"alternative-id":["S0959804921011710"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.10.017","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Significant decrease of the pathological stage I rectal carcinoma in the era of neoadjuvant therapy\u2014A matter of concern","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}